• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar for Jan. 21-25

 

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Andrew von Eschenbach, Commissioner, Food and Drugs1/23/08Washington, DCSusan Winckler, Daniel Schultz, Stephen Mason, Bill McConagha, LaJuana CaldwellGary Bisbee; John Dichiara; Charles Beck ; Michael Hutton (ReGen)To discuss marketing application for ReGen Collagen Scaffold, Menaflex
Andrew von Eschenbach, Commissioner, Food and Drugs1/24/08Washington, DCJanet Woodcock, Tim Stitely, Paul Seligman, Lisa Rovin, Melissa Robb, Norman Marks, Gina Kiang, Tom Gross, Dave Graham, John Dyer, Nancy Derr, Gerald Dalpan, Miles Braun, Rachel BehrmanN/ABrookings Roundtable Discussing Post-Market Evidence on Prescription Drugs
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer1/21/08 through 1/25/08N/AN/AN/ANo significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs1/22/08Rockville, MDSusan Winckler, Melinda Plaisier, John Stigi, David Horowitz, Wanda RussJanet Trunzo (AdvaMed); Ralph Ives (AdvaMed); David Kraph (Alcon; Dick DeRisio (AMO); Carolyn Albertson (Abbott); Susan Reardon (Johnson and Johnson); Sandy Kalter (Medtronic)International Activities
Randall Lutter, Deputy Commissioner for Policy1/21/08 through 1/25/08N/AN/AN/ANo significant meetings
Janet Woodcock, Deputy Commissioner for Scientific and Medical Programs,  Chief Medical Officer and Acting Director, Center for Drug Evaluation and Research1/25/08Silver Spring, MDJohn Jenkins, MD, Robert Temple, MDRichard Miller, MD, Pharmacyclics Frank Sasinowski, Josephine Torrente, Hyman, Phelps, & McNamaraMeet w/CEO of Pharmacyclics
Margaret Glavin, Associate Commissioner, Office of Regulatory Affairs1/21/08 through 1/25/08N/AN/AN/ANo significant meetings
Jesse Goodman, Director, Center for Biologics Evaluation and Research1/25/008Boston, MAN/AMassachusetts Biotechnology Council membersPolicy Decisions in 2008
Daniel Schultz, Director, Center for Devices and Radiological Health1/24/08Rockville, MDKyle Myers, Dave Brown, Nick Petrick, Donna Bea Tillman, Joyce Whang, Stacie Bilek, Steve GutmanMedical Imaging & Technology Alliance, Hans Beinke, Marilyn Waxberg, Arthur Friedman, John Pardo, Uri Shreter Ph.D., Stephen Slavens, Andy Whitman, Stephen Vastagh, Robert Uzenoff, Akira Hasegawa, Ms. Campbell Hutton, Michael ChilbertMedical device issues
Stephen Sundlof, Center for Food Safety and Applied Nutrition1/23/08College Park, MDFaye Feldstein, Director, Office of Food Safety, Defense and Outreach, Paul DiStefano, Office of  Food Additve Safety, Donald Kraemer, Office of Food Safety Bobby G. Savote, LA Oyster Task Force, Al Sunseri, P&J Oyster Co., Gulf Oyster Industry Council, Mike Voisin, GOIC, Teddy Busick, GOIC   Alerts of Oysters 
Stephen Sundlof, Center for Food Safety and Applied Nutrition1/23/08College Park, MDDr. Nega Beru, Director, Office of Food Safety, Wendy Buckler, Executive Operations StaffJulie Adams, Vice President of Almond Board of CaliforniaTo discuss the Almond  Board 
Bernadette Dunham, Director, Center for Veterinary Medicine1/21/08 through 1/25/08N/AN/AN/ANo significant meetings
William Slikker, Director, National Center for Toxicological Research1/24/08NCTR, Jefferson, ARNCTR StaffDavid Rainey, Arkansas State Representative, District 11Dr. Martin Luther King, Jr. Commemorative Luncheon & Program
Gerald Masoudi, Chief Counsel1/24/08Rockville, MDJeffrey Senger, Ann Wion, Donna Katz, OCCJohn Engel, Engel & Novitt, LLP; Ken Harley, Schering-Plough; Maureen McGirr, Merck & Co., Inc.; Peter Safir, Covington & BurlingCombination Policy